Meta Updates Hemp and CBD Advertising Policies
Updated: Aug 23
Meta Platforms, the parent company of social media companies such as Facebook and Instagram, has announced it will relax restrictions on advertisements for CBD and hemp products.
Meta’s announcement follows other large technology companies’ lifting outright bans on hemp and CBD products. Earlier this year, Twitter (now known as “X”) announced it had updated its paid advertising policies to allow approved CBD products to be advertised in the United States, but with strict limitations on messaging and products. Specifically, Twitter limits advertisements for the sale of CBD products to “topical (non-ingestible) hemp-derived CBD topical products containing equal to or less than the 0.3% THC government-set threshold.” Google also relaxed restrictions on CBD product advertisements, but only in certain states and with the approval of a third-party certification. Read more about Google’s policy updates here.
Meta’s policies require a LegitScript certification and prior written approval from Meta to advertise “legally permissible CBD products,” similar to Google’s required LegitScript certification. However, “non-ingestible and ingestible hemp products” may be advertised and do not require certification and approval. Meta defines “hemp products” as “ products made from the cannabis plant that do not contain CBD or more than 0.3% THC. Some examples may include hemp seed or hemp fiber. They include both ingestible and non-ingestible products.” Meta also has clarified that advertisements related to education, advocacy, or public service announcements discussing CBD and hemp are allowed, as long as advertisements are not attempting to sell a product and comply with Meta’s existing disclaimer policies related to social issues.
Have further questions regarding regulations on CBD and hemp products? Please schedule a consultation with EARTH Law, LLC to answer any questions regarding these updates. You can contact us by email at email@example.com or by telephone at 541-632-3946.